Product Liability Lawyer Blog

July 28, 2015

New Studies Show Link Between Xarelto and Stomach Bleeding – Eye Hemorrhaging

Xarelto is a member of a new class of oral anticoagulant medications proscribed to patients who suffer from a serious medical condition known as atrial fibrillation (Afib). Afib patients are at increased risk for certain types of serious medical conditions related to clotting disorders. When an Afib patient in not properly medicated, he or she is more likely to develop large and dangerous blood clots deep within his or her veins.

These clots can develop deep within the legs and break loose, causing a medical condition known as deep vein thrombosis (DVT). A DVT clot can then travel through the body’s circulatory system until it reaches a vital organ. The clot can puncture the lung, causing a pulmonary embolism (PE), which is often fatal to victims. Additionally, the clots can block the blood supply to the brain, causing the brain to be deprived of oxygen-rich blood and resulting in a stroke. Continue reading

July 25, 2015

A Look at Knee Replacement Options

by Jeffrey S. Glassman

Each year, more and more people are choosing to undergo total knee replacement surgery than in prior years. According to a recent report from Fox News, the American Academy of Orthopedic Surgeons estimates that over 600,000 patients undergo the procedure each year, and, by the year 2030, they estimate the number of total knee replacement patients will be over 2 million per year.

This is a huge number of people electing to have knee replacement surgery each year. However, when we use the term knee replacement, we are actually talking about two distinct types of procedures. The first type of procedure is known a partial knee replacement. In this type of operation, if the patient’s osteoarthritis is only in a single part of the knee joint, the doctor can remove the damaged material and use a partial knee replacement implant during surgery. Continue reading

July 22, 2015

Low T Study: Testosterone Replacement Therapy Doesn’t Fix Ejaculation Problems

by Jeffrey S. Glassman

The number of men taking hormone replacement therapy has gone up by over 400 percent in the past 10 years. The main reason for this is not because more men have developed the relatively rare medical condition known as hypogonadism (the only FDA approved reason for testosterone hormone), but because the drug companies have spent a lot of money marketing the hormone regimen for men who are experiencing the normal signs of male aging.

These signs of normal male aging include loss of libido, weight gain, tiredness, muscle fatigue and mild depression, among others. The makers of testosterone replacement therapy drugs and the owners and operators so called “T clinics” are using testosterone for the off-label use of allegedly treating these “symptoms” of the normal male aging process. Continue reading

July 18, 2015

Doctors Offering Outpatient Hip Replacement Surgery

by Jeffrey S. Glassman

There have been a lot of medical developments in hip surgery in the past decade. Hip surgery used to involve spending weeks in recovery in hospital, where extreme care was taken to not allow a patient to flex their hip joint more than 90 degrees. If a newly-implanted artificial hip was flexed or stress much in the two weeks following surgery, the joint could dislodge itself, causing a complete failure.

For this reason, special equipment was needed, including exercise mats that would rise up and down, and they could actually lift themselves up to waist level so a patient could get on and off without putting stress on the hip joint. There was a also a large scar following an equally large open incision where a spike was implanted deep in the patient’s femur to anchor the new artificial hip joint. However, with new technology being developed, and a major push from insurance companies wanting to reduce the rehabilitation time to keep costs down, patients are often sent home two days following a total hip replacement surgery. Continue reading

July 15, 2015

Studies on Using Pradaxa and Xarelto During Surgery

by Jeffrey S. Glassman

Pradaxa, Xarelto, and Eliquis are all members of a relatively new class of drugs known as new oral anticoagulants (NOACs). These drugs were designed for patients who suffer from a medical condition known as atrial fibrillation (Afib). Afib patients need a blood thinning medication to prevent deep vein clots from forming.

A deep vein clot can form a serous medical condition known as Deep Vein Thrombosis (DVT), where the clot forms in the veins of the legs and then breaks loose and travels though the blood system, where it can do serious damage. If the clot blocks the flow of blood to the brain, the patient will suffer a stroke, which can result in permanent injury or death. If the clot enters the lungs, it can puncture the pleural membrane, causing a serious internal bleeding condition known as a pulmonary embolism (PE). Continue reading

July 8, 2015

27,000 Pounds of Beef Recalled – Possible E. Coli Contamination

by Jeffrey S. Glassman

The Fourth of July and the surrounding days are lot of fun for families across the country. Many choose to invite friends and family over to their homes and have backyard cookouts. According to a recent feature from Food Safety News, there was food poisoning that led to the recall of nearly 30,000 pounds of beef. Specifically, there were concerns this beef was possibly contaminated with E. coli.

The meat was all produced in the state of Colorado and was shipped to restaurants and retailers in various states. The company issued the recall on July 3, 2015 after learning of the possible contamination and hoped they would be able to keep anyone from getting sick from eating contaminated beef on Independence Day. Continue reading

July 2, 2015

OtisMed CEO Sentenced for Shipping Defective Knee Replacement Products

by Jeffrey S. Glassman

We have seen a variety of different defective artificial knee replacement devices, and many of these defective products have been the result of negligence committed by various medical device manufacturers. We have seen problems with artificial joints manufactured by Stryker, DePuy, OtisMed and others.

What makes things different in the Case of OtisMed is that the CEO pleaded guilty to knowingly shipping knee replacement products after the United States Food and Drug Administration (FDA) denied an approval request to ship the articular product. In other words, the FDA found a particular knee replacement product did not have enough safety data and may be defective, but, as he admitted to in a criminal court in New Jersey, the owner decided to disregard the denial. Continue reading

June 29, 2015

Managing Joint Replacement Risks

by Jeffrey S. Glassman

Over the past decade, we have seen a tremendous increase in the number of patients electing to undergo total joint replacement surgery. This can include total knee replacement surgery, total hip replacement surgery, and even other newer surgical procedures, such as a total ankle replacement surgery. All of these total joint replacement surgeries involve the implantation of an artificial joint to reconstruct or replace the damaged joint through a medical process known as arthroplasty.

Even if the surgeon performs these surgeries flawlessly and the artificial joint implanted was properly designed and functioning, there is still a significant amount of risk a patient will face when electing to undergo total joint replacement surgery.

According to a recent feature article from U.S. News and World Report, it is important to manage joint replacement risks appropriately, so patients can get back on their feet sooner. Continue reading

June 26, 2015

Testosterone Levels Vary Throughout the Day with Hormone Patch

by Jeffrey S. Glassman

Testosterone replacement therapy is clearly a big money maker for the various pharmaceutical companies that manufacture the hormone. It has gotten to the point where you cannot watch a football game or NASCAR race without seeing more than one commercial for testosterone replacement hormone.

Testosterone replacement therapy hormone comes in a variety of forms, including injections, transdermal patches, gels, skin creams, sublingual films, and pills. They are heavily marketed to men who are experiencing the symptoms of normal male aging, including reduced libido, weight gain, loss of muscle tone, fatigue, and mild depression.

While the companies that make testosterone replacement therapy hormone say taking replacement hormone is essentially a quick fix for all of these symptoms or characteristics, many doctors are not so sure. The medical community is not sure what it means to have low testosterone and what is normal for aging men. They also do not know if there is any benefit to raising one’s testosterone level though taking hormone therapy, unless the patient’s levels are so low as to qualify for the rare disease of hypogonadism. Continue reading

June 23, 2015

Robotic Hip Surgery Purports to be Safer, Some Evidence Suggests Otherwise

by Jeffrey S. Glassman

In Minnesota, a local news article touted a new robotic surgery for total hip replacements at a nearby hospital. The article noted surgeons were relying less on the imperfect human eye and fallible human hand and instead leaning on the precision of robots.

The latest investment for the local surgical center costs millions of dollars. It’s an arm-assisted system, and promises to “take the guesswork” out of placement of hip replacement implants, allowing patients to receive fits that are customized. It’s one of two surgical centers in that state to use the robotic arm system, which was manufactured by Stryker – the same company at the center of hip replacement and knee replacement litigation for defective products.

Approximately 400 to 550 hip replacements are done at this surgical center alone each year. The hope is to reduce the number of additional surgeries sometimes needed to correct improper placement of hip replacements, which is largely attributed to “eyeballing techniques” used by surgeons to get the parts in the right place.